Compare AMCX & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMCX | OFIX |
|---|---|---|
| Founded | 1980 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 492.0M | 481.0M |
| IPO Year | 2011 | 1998 |
| Metric | AMCX | OFIX |
|---|---|---|
| Price | $11.77 | $10.33 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $7.33 | ★ $17.25 |
| AVG Volume (30 Days) | ★ 795.9K | 355.0K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 132.55 | 29.39 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,311,801,000.00 | $822,312,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $6.22 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $6.47 | $8.85 |
| 52 Week High | $12.52 | $16.99 |
| Indicator | AMCX | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 64.42 | 41.27 |
| Support Level | $9.23 | $8.99 |
| Resistance Level | N/A | $10.58 |
| Average True Range (ATR) | 0.68 | 0.63 |
| MACD | 0.16 | -0.23 |
| Stochastic Oscillator | 79.69 | 7.69 |
AMC Global Media owns several linear TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network,reached 55 million pay TV households in the US at the end of 2025. The firm also had nearly 10.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.